methylprednisolone hemisuccinate has been researched along with Hodgkin Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apjok, E; Magyarosy, E; Marosi, A | 1 |
| Ahmed, T; Chun, H; Coleman, M; Cook, P; Coombe, N; Feldman, E; Helson, L; Mittelman, A; Puccio, C | 1 |
| Andersson, B; Cabanillas, F; Fayad, L; Hagemeister, FB; McLaughlin, P; Rodriguez, J; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F | 1 |
| Braumann, D; Fiedler, F; Hänel, A; Hänel, M; Hoffknecht, MM; Hossfeld, DK; Illiger, HJ; Kröger, N; Krüger, WH; Metzner, B; Peters, SO; Schubert, JC; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Flombaum, CD; Schroy, P; Vanamee, P; Watson, R | 1 |
3 trial(s) available for methylprednisolone hemisuccinate and Hodgkin Disease
| Article | Year |
|---|---|
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged | 1994 |
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Recurrence; Survival Analysis | 1999 |
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged; Recurrence; Salvage Therapy; Survival Analysis | 2000 |
2 other study(ies) available for methylprednisolone hemisuccinate and Hodgkin Disease
| Article | Year |
|---|---|
[Guillain-Barré syndrome in patients treated for Hodgkin disease].
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Guillain-Barre Syndrome; Hodgkin Disease; Humans; Male; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Paraneoplastic Syndromes, Nervous System; Treatment Outcome | 2003 |
Treatment of acute obstructive renal failure with high-dose methylprednisolone.
Topics: Acute Kidney Injury; Aged; Edema; Female; Hodgkin Disease; Humans; Injections, Intravenous; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Ureteral Obstruction; Uterine Cervical Neoplasms | 1986 |